Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ CHP1 Monoclonal Antibody (OTI1D11)
Mouse Monoclonal Antibody
Supplier: Invitrogen™ MA527264
Description
CHP1 Monoclonal Antibody for Western Blot, IHC (P)
Regulates centrosome duplication, probably by inhibiting the kinase activity of ROCK2. Proposed to act as co-chaperone for HSP90. May play a role in the regulation of NOD1 via a HSP90 chaperone complex. In vitro, has intrinsic chaperone activity. This function may be achieved by inhibiting association of ROCK2 with NPM1. Involved in stress response. Prevents tumorigenesis.
Specifications
CHP1 | |
Monoclonal | |
1 mg/mL | |
PBS with 1% BSA, 50% glycerol and 0.02% sodium azide; pH 7.3 | |
Q99653 | |
CHP1 | |
Full length human recombinant protein of CHP1 produced in HEK293T cell. | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG1 |
Immunohistochemistry (Paraffin), Western Blot | |
OTI1D11 | |
Unconjugated | |
CHP1 | |
1500003O03Rik; AA960066; AI046351; Cahp; calcineurin B homolog; calcineurin B homologous protein 1; Calcineurin B-like protein; calcineurin homologous protein; calcineurin like EF-hand protein 1; calcineurin-like EF hand protein 1; calcineurin-like EF-hand protein 1; calcium binding protein P22; calcium-binding protein CHP; Calcium-binding protein p22; CHP; chp1; Chromo domain-containing protein 1; chromodomain protein Chp1; EF-hand Ca2+-binding protein p22; EF-hand calcium-binding domain-containing protein p22; p22; p24; si:dkey-41n20.1; sid 470; Sid470; Sid470p; SLC9A1 binding protein; SLC9A1BP; SPAC18G6.02c; Unknown (protein for MGC:127971); Unknown (protein for MGC:63904); vac; Wrch2; wu:fc69b04; zgc:63904 | |
Mouse | |
Affinity Chromatography | |
RUO | |
11261 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction